| For: | Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, Xu LM, Liu CH, Gu HT, Zhang ZQ. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002; 8(4): 679-685 [PMID: 12174378 DOI: 10.3748/wjg.v8.i4.679] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i4/679.htm |
| Number | Citing Articles |
| 1 |
He-He Hu, Dan-Qian Chen, Yan-Ni Wang, Ya-Long Feng, Gang Cao, Nosratola D. Vaziri, Ying-Yong Zhao. New insights into TGF-β/Smad signaling in tissue fibrosis. Chemico-Biological Interactions 2018; 292 doi: 10.1016/j.cbi.2018.07.008
|
| 2 |
Warren Chanda, Petty M. Miyanda, Kingsley Kamvuma, Zainab M. Almarhoon, Javad Sharifi-Rad, William N. Setzer, Daniela Calina. Salvianolic acid B in cancer therapy: pharmacokinetic profile, anticancer mechanisms and translational potential. Medical Oncology 2025; 42(8) doi: 10.1007/s12032-025-02892-1
|
| 3 |
Xin Zhao, Hongmei Jia, Shijun Yang, Yuetao Liu, Bo Deng, Xueyan Xu, Tao Zhang, Hang Zhou, Chengzhe Zu, He Yin, Ting Li, Yijun Song, Yueqi Wang, Pengtao Li, Zhongmei Zou, Dayong Cai. Salvianolic Acid B Reducing Portal Hypertension Depends on Macrophages in Isolated Portal Perfused Rat Livers with Chronic Hepatitis. Evidence-Based Complementary and Alternative Medicine 2012; 2012 doi: 10.1155/2012/786365
|
| 4 |
Florent Duval, Jorge E. Moreno-Cuevas, Maria Teresa González-Garza, Carlos Rodríguez-Montalvo, Delia Elva Cruz-Vega. Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells. Advances in Pharmacological Sciences 2014; 2014 doi: 10.1155/2014/373295
|
| 5 |
Zhigang Lv, Lieming Xu. Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways. Evidence-Based Complementary and Alternative Medicine 2012; 2012 doi: 10.1155/2012/960128
|
| 6 |
Ping Liu. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action. Chinese Journal of Integrative Medicine 2012; 18(5) doi: 10.1007/s11655-012-1030-1
|
| 7 |
Rong Wang, Xiao-Yan Yu, Zhu-Ying Guo, Yu-Jie Wang, Yan Wu, Yong-Fang Yuan. Inhibitory effects of salvianolic acid B on CCl4-induced hepatic fibrosis through regulating NF-κB/IκBα signaling. Journal of Ethnopharmacology 2012; 144(3) doi: 10.1016/j.jep.2012.09.048
|
| 8 |
XiaoYan Gao, XiuDan Li, CongYing Zhang, Jing Zhou, Kai Gu, XiaoQiang Liu, ChunYing Bai. Inhibiting TGF-β signaling pathway for disease therapy: challenges and opportunities. Cytokine 2025; 196 doi: 10.1016/j.cyto.2025.157048
|
| 9 |
Nikolaos Pyrsopoulos, Zaid H Tafesh, Konstantinos Damiris. Efficacy and safety of anti-hepatic fibrosis drugs. World Journal of Gastroenterology 2020; 26(41): 6304-6321 doi: 10.3748/wjg.v26.i41.6304
|
| 10 |
Wenwei Zhang, Jian Ping, Yang Zhou, Gaofeng Chen, Lieming Xu. Salvianolic Acid B Inhibits Activation of Human Primary Hepatic Stellate Cells Through Downregulation of the Myocyte Enhancer Factor 2 Signaling Pathway. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00322
|
| 11 |
Yan-Meng Lu, Jiao-Jiao Xie, Cong-Gao Peng, Bao-Hong Wang, Kai-Cen Wang, Lan-Juan Li. Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese Medicine. Engineering 2019; 5(1) doi: 10.1016/j.eng.2018.11.013
|
| 12 |
Rolf Teschke, Albrecht Wolff, Christian Frenzel, Axel Eickhoff, Johannes Schulze. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World Journal of Gastroenterology 2015; 21(15): 4466-4490 doi: 10.3748/wjg.v21.i15.4466
|
| 13 |
Devaraj Ezhilarasan. Phytochemicals as Lead Compounds for New Drug Discovery. 2020; doi: 10.1016/B978-0-12-817890-4.00012-3
|
| 14 |
Md. Oliullah Rafi, Khattab Al-Khafaji, Tugba Taskin Tok, Md. Shahedur Rahman.
Computer-based identification of potential compounds from
Salviae miltiorrhizae
against Neirisaral adhesion A regulatory protein
. Journal of Biomolecular Structure and Dynamics 2022; 40(10) doi: 10.1080/07391102.2020.1856189
|
| 15 |
Zhenjian Lin, Yuyan Bao, Bing Hong, Yangyang Wang, Xiaomin Zhang, Yaping Wu. Salvianolic acid B attenuated cisplatin-induced cardiac injury and oxidative stress via modulating Nrf2 signal pathway. The Journal of Toxicological Sciences 2021; 46(5) doi: 10.2131/jts.46.199
|
| 16 |
Fujun Yu, Zhongqiu Lu, Kate Huang, Xiaodong Wang, Ziqiang Xu, Bicheng Chen, Peihong Dong, Jianjian Zheng. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis. Oncotarget 2016; 7(1) doi: 10.18632/oncotarget.6447
|
| 17 |
Gang Yao, Lizhi Xu, Xiaochun Wu, Lingling Xu, Junwei Yang, Huimei Chen. Preventive Effects of Salvianolic Acid B on Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition of Human Kidney Cells. Biological & Pharmaceutical Bulletin 2009; 32(5) doi: 10.1248/bpb.32.882
|
| 18 |
Yibin Feng, Kwok-Fan Cheung, Ning Wang, Ping Liu, Tadashi Nagamatsu, Yao Tong. Chinese medicines as a resource for liver fibrosis treatment. Chinese Medicine 2009; 4(1) doi: 10.1186/1749-8546-4-16
|
| 19 |
Wen-yu Wu, Yi-ping Wang. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacologica Sinica 2012; 33(9) doi: 10.1038/aps.2012.126
|
| 20 |
Zhe Ma, Bing Zhang, Yuqi Fan, Meng Wang, Dereje Kebebe, Jiawei Li, Zhidong Liu. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomedicine & Pharmacotherapy 2019; 117 doi: 10.1016/j.biopha.2019.109128
|
| 21 |
Li Wang, Zhao-Hong Shi, Jie-Ping Yu, Yan-Jun Luo. Ginkgo biloba extract reverses CCl<sub>4</sub>–induced liver fibrosis in rats. World Journal of Gastroenterology 2004; 10(7): 1037-1042 doi: 10.3748/wjg.v10.i7.1037
|
| 22 |
Jian Hou, Jingwei Tian, Wanglin Jiang, Yubai Gao, Fenghua Fu. Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis. European Journal of Pharmacology 2011; 650(1) doi: 10.1016/j.ejphar.2010.10.019
|
| 23 |
Xiaoxi Zhou, Yadong Fu, Jiamei Chen, Ping Liu. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis. Journal of Ethnopharmacology 2024; 327 doi: 10.1016/j.jep.2024.118018
|
| 24 |
Florent Duval, Jorge E Moreno-Cuevas, María Teresa González-Garza, Carlos Rodríguez-Montalvo, Delia Elva Cruz-Vega. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chinese Medicine 2014; 9(1) doi: 10.1186/s13020-014-0027-4
|
| 25 |
Shu-Ling Kan, Jin Li, Jian-Ping Liu, Yi Zhao. Preparation andIVIVCevaluation of salvianolic acid B micro-porous osmotic pump pellets. Drug Development and Industrial Pharmacy 2015; 41(3) doi: 10.3109/03639045.2013.879722
|
| 26 |
Sanna Huttunen, Marko Toivanen, Chenghai Liu, Carina Tikkanen-Kaukanen. Novel anti-infective potential of salvianolic acid B against human serious pathogen Neisseria meningitidis. BMC Research Notes 2016; 9(1) doi: 10.1186/s13104-016-1838-4
|
| 27 |
K. Chan, S.H. Chui, D.Y.L. Wong, W.Y. Ha, C.L. Chan, R.N.S. Wong. Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sciences 2004; 75(26) doi: 10.1016/j.lfs.2004.06.010
|
| 28 |
Kaili Hu, Lei Miao, Tyler J. Goodwin, Jun Li, Qi Liu, Leaf Huang. Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. ACS Nano 2017; 11(5) doi: 10.1021/acsnano.7b01522
|
| 29 |
Yan He, Kun Jia, Lei Li, Qi Wang, Shuhui Zhang, Jiaming Du, Heng Du. Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons. Biochemical and Biophysical Research Communications 2018; 498(4) doi: 10.1016/j.bbrc.2018.03.119
|
| 30 |
Jianyang Pan, Xingchu Gong, Haibin Qu. Quantitative 1H NMR method for hydrolytic kinetic investigation of salvianolic acid B. Journal of Pharmaceutical and Biomedical Analysis 2013; 85 doi: 10.1016/j.jpba.2013.06.020
|
| 31 |
Tun-Pin Hsueh, Wan-Ling Lin, Tung-Hu Tsai. Pharmacokinetic interactions of herbal medicines for the treatment of chronic hepatitis. Journal of Food and Drug Analysis 2017; 25(2) doi: 10.1016/j.jfda.2016.11.010
|
| 32 |
Detlef Schuppan. Liver fibrosis: Common mechanisms and antifibrotic therapies. Clinics and Research in Hepatology and Gastroenterology 2015; 39 doi: 10.1016/j.clinre.2015.05.005
|
| 33 |
Tung‐Lin Yang, Fen‐Yen Lin, Yung‐Hsiang Chen, Jeng‐Jiann Chiu, Ming‐Shi Shiao, Chien‐Sung Tsai, Shing‐Jong Lin, Yuh‐Lien Chen. Salvianolic acid B inhibits low‐density lipoprotein oxidation and neointimal hyperplasia in endothelium‐denuded hypercholesterolaemic rabbits. Journal of the Science of Food and Agriculture 2011; 91(1) doi: 10.1002/jsfa.4163
|
| 34 |
Miao Liu, Mingjing Zheng, Hanying Xu, Lianqing Liu, Yanchun Li, Wei Xiao, Jianchun Li, Enlong Ma. Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties. Biochemical and Biophysical Research Communications 2015; 468(1-2) doi: 10.1016/j.bbrc.2015.10.127
|
| 35 |
Detlef Schuppan, Yong Ook Kim. Evolving therapies for liver fibrosis. Journal of Clinical Investigation 2013; 123(5) doi: 10.1172/JCI66028
|
| 36 |
力飞 宋. Determination of Corilagin and Salvianolic Acid B in Fu Zheng Rou Gan by HPLC. Pharmacy Information 2015; 4(04) doi: 10.12677/PI.2015.44006
|
| 37 |
Jiamei Chen, Benjamin Tschudy-Seney, Xiaocui Ma, Mark A. Zern, Ping Liu, Yuyou Duan. Salvianolic Acid B Enhances Hepatic Differentiation of Human Embryonic Stem Cells Through Upregulation of WNT Pathway and Inhibition of Notch Pathway. Stem Cells and Development 2018; 27(4) doi: 10.1089/scd.2017.0168
|
| 38 |
Qingzhi Liang, Xiaoqin Liu, Xi Peng, Ting Luo, Yi Su, Xin Xu, Hongyan Xie, Hong Gao, Zhengtao Chen, Chunguang Xie. Salvianolic acid B in fibrosis treatment: a comprehensive review. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1442181
|
| 39 |
Jiahao Lin, Xiuli Wang, Qing Wu, Jundong Dai, Huida Guan, Weiyi Cao, Liangying He, Yurong Wang. Development of Salvianolic acid B–Tanshinone II A–Glycyrrhetinic acid compound liposomes: Formulation optimization and its effects on proliferation of hepatic stellate cells. International Journal of Pharmaceutics 2014; 462(1-2) doi: 10.1016/j.ijpharm.2013.12.040
|
| 40 |
Rong-hua Pan, Feng-yan Xie, Hui-mei Chen, Li-zhi Xu, Xiao-chun Wu, Ling-ling Xu, Gang Yao. Salvianolic acid B reverses the epithelial-to-mesenchymal transition of HK-2 cells that is induced by transforming growth factor-β. Archives of Pharmacal Research 2011; 34(3) doi: 10.1007/s12272-011-0317-7
|
| 41 |
Tao Jiang, Guangji Zhang, Zhaohuan Lou. Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01788
|
| 42 |
Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972
|
| 43 |
Li Cao, Jian Zhou, Jinhua Wen. Transport of salvianolic acid B via the human organic anion transporter 1B1 in the liver. Phytotherapy Research 2019; 33(1) doi: 10.1002/ptr.6216
|
| 44 |
Jing Li, Xiaoqin Liu, Haoyue Feng. Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1831031
|
| 45 |
Chao‐Feng Chien, Yu‐Tse Wu, Tung‐Hu Tsai. Biological analysis of herbal medicines used for the treatment of liver diseases. Biomedical Chromatography 2011; 25(1-2) doi: 10.1002/bmc.1568
|
| 46 |
Qingmei Liu, Haiyan Chu, Yanyun Ma, Ting Wu, Feng Qian, Xian Ren, Wenzhen Tu, Xiaodong Zhou, Li Jin, Wenyu Wu, Jiucun Wang. Salvianolic Acid B Attenuates Experimental Pulmonary Fibrosis through Inhibition of the TGF-β Signaling Pathway. Scientific Reports 2016; 6(1) doi: 10.1038/srep27610
|
| 47 |
Jiamei Chen, Yonghong Hu, Long Chen, Wei Liu, Yongping Mu, Ping Liu. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomedicine & Pharmacotherapy 2019; 114 doi: 10.1016/j.biopha.2019.108846
|
| 48 |
Yuyue Qiu, Xiaoni Shao. Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications. Drug Design, Development and Therapy 2025; doi: 10.2147/DDDT.S524008
|
| 49 |
Rachel B. Wilson, Jason J. Lee, J. Geoffrey Pickering, Nica M. Borradaile. Regenerative Nephrology. 2022; doi: 10.1016/B978-0-12-823318-4.00027-5
|
| 50 |
Jie Liu, Yun Shi, Daiyin Peng, Lei Wang, Nianjun Yu, Guokai Wang, Weidong Chen. Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.842980
|
| 51 |
Eric Yarnell, Kathy Abascal. Herbal Medicine for Viral Hepatitis. Alternative and Complementary Therapies 2010; 16(3) doi: 10.1089/act.2010.16308
|
| 52 |
Robert Domitrović, Iva Potočnjak. A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives. Archives of Toxicology 2016; 90(1) doi: 10.1007/s00204-015-1580-z
|
| 53 |
Jun Shi, Siyi Guo, Yanting Wu, Guitian Chen, Jianhui Lai, Xiaoqi Xu. Behaviour of cell penetrating peptide TAT-modified liposomes loaded with salvianolic acid B on the migration, proliferation, and survival of human skin fibroblasts. Journal of Liposome Research 2020; 30(1) doi: 10.1080/08982104.2019.1593451
|
| 54 |
Hui Wang, Yufei Chang, Xiao Liu, Linan Liu, Mingxi Hua, Ang Li. Protective effects of baicalin on diethyl nitrosamine‐induced liver cirrhosis by suppressing oxidative stress and inflammation. Chemical Biology & Drug Design 2024; 103(1) doi: 10.1111/cbdd.14386
|
| 55 |
Wenjing Zeng, Wen Shan, Lili Gao, Dongyan Gao, Yan Hu, Guangzhi Wang, Ning Zhang, Zhenlu Li, Xiaofeng Tian, Wei Xu, Jinyong Peng, Xiaochi Ma, Jihong Yao. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Scientific Reports 2015; 5(1) doi: 10.1038/srep16013
|
| 56 |
Min Zhang, Shu-Ren Cao, Rui Zhang, Jin-Lan Jin, You-Feng Zhu. The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts. Experimental Lung Research 2014; 40(4) doi: 10.3109/01902148.2014.895070
|
| 57 |
Si-Ming Wei, Yu-Min Huang, Hassan Obied. Attenuation Effect of Salvianolic Acid B on Testicular Ischemia‐Reperfusion Injury in Rats. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/7680182
|
| 58 |
Yau-Tuen Chan, Ning Wang, Hor Yue Tan, Sha Li, Yibin Feng. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00548
|
| 59 |
De‐En Han, Zi‐Dong Gao, Di Zhao, Lei Wang, Na Li, Ting‐Ting Li, Lei Wu, Xi‐Jing Chen. Liquid chromatography mass spectrometry for the determination of salvianolic acid B, a natural compound from the herb Danshen in rat plasma and application to pharmacokinetic study. Biomedical Chromatography 2009; 23(10) doi: 10.1002/bmc.1225
|
| 60 |
Fatma Tugce Guragac Dereli, Ali Guragac, Tarun Belwal. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; doi: 10.1016/B978-0-12-816488-4.00011-5
|
| 61 |
Yun-Lian Lin, Ting-Fang Lee, Yeh-Jeng Huang, Yi-Tsau Huang. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. Journal of Pharmacy and Pharmacology 2006; 58(7) doi: 10.1211/jpp.58.7.0008
|
| 62 |
Lihong Zhang, Limei Han, Xun Sun, Dongyan Gao, Jing Qin, Jianxin Wang. The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B. Fitoterapia 2012; 83(4) doi: 10.1016/j.fitote.2012.02.004
|
| 63 |
Pi-Long Wang, Chun-Tao Lei, Ming-De Jiang, Xiao-Bin Chen, Yong Zhang, Hui Xu, Zhao Wang, Wei-Zheng Zeng, Xiao-Ling Wu. Effect of compound rhodiola sachalinensis A Bor on CCl<sub>4</sub>-induced liver fibrosis in rats and its probable molecular mechanisms. World Journal of Gastroenterology 2003; 9(7): 1559-1562 doi: 10.3748/wjg.v9.i7.1559
|
| 64 |
Chengu Niu, Jing Zhang, Patrick I Okolo. The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols. Pharmacological Reports 2024; 76(5) doi: 10.1007/s43440-024-00638-w
|
| 65 |
Li-rui Tang, Yan-yan Tao, Cheng-hai Liu, Hai-nan Wang. Salvianolate Reduces Glucose Metabolism Disorders in Dimethylnitrosamine-Induced Cirrhotic Rats. Chinese Journal of Integrative Medicine 2018; 24(9) doi: 10.1007/s11655-017-2773-5
|
| 66 |
John M. Luk, Xiaoling Wang, Ping Liu, Kwong‐Fai Wong, Kwong‐Leung Chan, Yao Tong, Chi‐Kin Hui, George K. Lau, Sheung‐Tat Fan. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. Liver International 2007; 27(7) doi: 10.1111/j.1478-3231.2007.01527.x
|
| 67 |
Xiao-Wen Jiang, Yi Zhang, Shou-Kang Yang, Hao Zhang, Kun Lu, Guo-Liang Sun. Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2013; 115(3) doi: 10.1016/j.oooo.2012.10.006
|
| 68 |
Chao Wu, Weiyang Chen, Hanyan Ding, Dong Li, Guanghua Wen, Chong Zhang, Wanpeng Lu, Ming Chen, Yan Yang. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro. Life Sciences 2019; 239 doi: 10.1016/j.lfs.2019.116881
|
| 69 |
Xiuchuan Yan, Tao Zhou, Yanyan Tao, Qinglan Wang, Ping Liu, Chenghai Liu. Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways. Experimental Biology and Medicine 2010; 235(5) doi: 10.1258/ebm.2009.009293
|
| 70 |
Huaizhi Li, Yan Cheng, Hongjing Dong, Xiao Wang, Jia Li, Qianshan Gao. Preparation of salvianolic acid A by the degradation reaction of salvianolic acid B in subcritical water integrated with pH-zone-refining counter-current chromatography. Journal of Chromatography A 2016; 1468 doi: 10.1016/j.chroma.2016.09.039
|
| 71 |
Musen Lin, Xiaohan Zhai, Guangzhi Wang, Xiaofeng Tian, Dongyan Gao, Lei Shi, Hang Wu, Qing Fan, Jinyong Peng, Kexin Liu, Jihong Yao. Salvianolic acid B protects against acetaminophen hepatotoxicity by inducing Nrf2 and phase II detoxification gene expression via activation of the PI3K and PKC signaling pathways. Journal of Pharmacological Sciences 2015; 127(2) doi: 10.1016/j.jphs.2014.12.010
|
| 72 |
Angela Douglass, Karen Wallace, Matthew Koruth, Caroline Barelle, Andrew J. Porter, Matthew C. Wright. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatology International 2008; 2(4) doi: 10.1007/s12072-008-9093-y
|
| 73 |
Shu Li, Lina Wang, Xiuchuan Yan, Qinglan Wang, Yanyan Tao, Junxia Li, Yuan Peng, Ping Liu, Chenghai Liu. Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling. Evidence-Based Complementary and Alternative Medicine 2012; 2012 doi: 10.1155/2012/160726
|
| 74 |
Fu-Cheng Ma, Yan-Fang Liu, Wan-An Shen, Hui-Zhong Zhang, Hong Cheng. Expression of RNase H of human hepatitis B virus polymerase in <italic>Escherichia coli</italic>. World Journal of Gastroenterology 2003; 9(3): 513-515 doi: 10.3748/wjg.v9.i3.513
|
| 75 |
Yunxia Liu, Yingying Hu, Qiukai E, Ji Zuo, Ling Yang, Wen Liu. Salvianolic acid B inhibits mitochondrial dysfunction by up-regulating mortalin. Scientific Reports 2017; 7(1) doi: 10.1038/srep43097
|
| 76 |
Yongfang Gong, Dong Li, Lili Li, Juan Yang, Hanyan Ding, Chong Zhang, Guanhua Wen, Chao Wu, Zhirui Fang, Shu Hou, Yan Yang. Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis. Food and Chemical Toxicology 2021; 147 doi: 10.1016/j.fct.2020.111912
|
| 77 |
Yanan Shi, Da Pan, Lihui Yan, Hengyu Chen, Ximei Zhang, Jihong Yuan, Biao Mu. Salvianolic acid B improved insulin resistance through suppression of hepatic ER stress in ob/ob mice. Biochemical and Biophysical Research Communications 2020; 526(3) doi: 10.1016/j.bbrc.2020.03.124
|
| 78 |
Xiaoyi Li, Lixin Zhu, Beibei Wang, Meifei Yuan, Ruixin Zhu. Drugs and Targets in Fibrosis. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00855
|
| 79 |
Yadong Fu, Xiaoxi Zhou, Lin Wang, Weiguo Fan, Siqi Gao, Danyan Zhang, Zhiyang Ling, Yaguang Zhang, Liyan Ma, Fang Bai, Jiamei Chen, Bing Sun, Ping Liu. Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis. Redox Biology 2024; 69 doi: 10.1016/j.redox.2024.103029
|
| 80 |
Fujun Yu, Zhongqiu Lu, Bicheng Chen, Xiaoli Wu, Peihong Dong, Jianjian Zheng. Salvianolic acid B‐induced microRNA‐152 inhibits liver fibrosis by attenuating DNMT1‐mediated Patched1 methylation. Journal of Cellular and Molecular Medicine 2015; 19(11) doi: 10.1111/jcmm.12655
|
| 81 |
|
| 82 |
Sarasadat Hosseini, Mohsen Imenshahidi, Hossein Hosseinzadeh, Gholamreza Karimi. Effects of plant extracts and bioactive compounds on attenuation of bleomycin-induced pulmonary fibrosis. Biomedicine & Pharmacotherapy 2018; 107 doi: 10.1016/j.biopha.2018.08.111
|
| 83 |
Reshu Virmani, Kamla Pathak. Herbal Bioactive-Based Drug Delivery Systems. 2022; doi: 10.1016/B978-0-12-824385-5.00007-8
|
| 84 |
Min Zhang, Huihua Yang, Xian Chen, Yongchuan Zhou, Hongyang Zhang, Yuerong Wang, Ping Hu. In-situ extraction and separation of salvianolic acid B from Salvia miltiorrhiza Bunge by integrated expanded bed adsorption. Separation and Purification Technology 2011; 80(3) doi: 10.1016/j.seppur.2011.06.039
|
| 85 |
Shao-Bai Li, Qin Li, Mei Liu, Guo Zhang, Cui-Huan Wu, Hong-Mei Yan, Zi-Li Dan, Wang-Xian Tang. Experimental study of effect of Ganyanping on fibrosis in rat livers. World Journal of Gastroenterology 2003; 9(6): 1292-1295 doi: 10.3748/wjg.v9.i6.1292
|
| 86 |
Xiao-Zhou Zou, Ting Liu, Zhi-Cheng Gong, Chang-Ping Hu, Zheng Zhang. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. European Journal of Pharmacology 2017; 796 doi: 10.1016/j.ejphar.2016.12.003
|
| 87 |
Shan Li, Fangmin Song, Xu Lei, Jingtao Li, Fang Li, Huabing Tan. hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis. Aging 2020; 12(12) doi: 10.18632/aging.103257
|
| 88 |
Yingchun Shao, Li Zhai, Shan Jiang, Fusheng Sun, Xuedong Liu. Salvianolic acid B: a promising cardioprotective agent. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1681358
|
| 89 |
Liping Cao, Guojun Yin, Jinliang Du, Rui Jia, Jiancao Gao, Nailin Shao, Quanjie Li, Haojun Zhu, Yao Zheng, Zhijuan Nie, Weidong Ding, Gangchun Xu. Salvianolic Acid B Regulates Oxidative Stress, Autophagy and Apoptosis against Cyclophosphamide-Induced Hepatic Injury in Nile Tilapia (Oreochromis niloticus). Animals 2023; 13(3) doi: 10.3390/ani13030341
|
| 90 |
Sergio García-Muñoz, Míriam Álvarez-Corral, Leticia Jiménez-González, Cristóbal López-Sánchez, Antonio Rosales, Manuel Muñoz-Dorado, Ignacio Rodríguez-García. Synthesis of dihydrodehydrodiconiferyl alcohol and derivatives through intramolecular C–H insertion. Tetrahedron 2006; 62(52) doi: 10.1016/j.tet.2006.10.018
|
| 91 |
Guang‐De Yang, Hui Zhang, Rong Lin, Wei‐Rong Wang, Xiao‐Lian Shi, Yu Liu, Qiao‐Li Ji. Down‐Regulation of CD40 Gene Expression and Inhibition of Apoptosis with Danshensu in Endothelial Cells. Basic & Clinical Pharmacology & Toxicology 2009; 104(2) doi: 10.1111/j.1742-7843.2008.00342.x
|
| 92 |
Yan-Yan Tao, Qing-Lan Wang, Li Shen, Wen-Wei Fu, Cheng-Hai Liu. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathwayin vivoandin vitro. Experimental Biology and Medicine 2013; 238(11) doi: 10.1177/1535370213498979
|
| 93 |
Dong Ji, Guo-Feng Chen, Jin-Cheng Wang, Si-Han Ji, Xue-Wen Wu, Xiao-Jie Lu, Jin-Lian Chen, Jing-Tao Li. Hsa_circ_0070963 inhibits liver fibrosis via regulation of miR-223-3p and LEMD3. Aging 2020; 12(2) doi: 10.18632/aging.102705
|
| 94 |
Qing-Lan Wang, Yan-Yan Tao, Ji-Li Yuan, Li Shen, Cheng-Hai Liu. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro. BMC Cell Biology 2010; 11(1) doi: 10.1186/1471-2121-11-31
|
| 95 |
Meina Zhao, Fei Mu, Rui Lin, Kai Gao, Wei Zhang, Xingru Tao, Dong Xu, Jingwen Wang. Chinese Medicine-Derived Salvianolic Acid B for Disease Therapy: A Scientometric Study. The American Journal of Chinese Medicine 2024; 52(05) doi: 10.1142/S0192415X2450054X
|
| 96 |
Zhigang Lv, Yafang Song, Dongying Xue, Wenwei Zhang, Yang Cheng, Lieming Xu. Effect of Salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells. Journal of Ethnopharmacology 2010; 132(2) doi: 10.1016/j.jep.2010.05.026
|
| 97 |
Yueming Ma, Tianming Wang. A solid‐phase extraction method for high‐performance liquid chromatographic determination of salvianolic acid B in rabbit plasma: application to pharmacokinetic study. Biomedical Chromatography 2007; 21(2) doi: 10.1002/bmc.741
|
| 98 |
Mingzhu Li, Yang Lu, Yan Hu, Xiaohan Zhai, Wei Xu, Huirong Jing, Xiaofeng Tian, Yuan Lin, Dongyan Gao, Jihong Yao. Salvianolic acid B protects against acute ethanol-induced liver injury through SIRT1-mediated deacetylation of p53 in rats. Toxicology Letters 2014; 228(2) doi: 10.1016/j.toxlet.2014.04.011
|
| 99 |
Li Yanxin, Zhang Luwen, Li Ming, Liu Xincan, Lan Zhenzhen, Wang Wei, Chen Lei. Natural Compounds Targeting Profibrotic Signaling Pathways in Myocardial Fibrosis: Signaling Network Regulation and Therapeutic Potential. Natural Product Communications 2026; 21(5) doi: 10.1177/1934578X261454083
|
| 100 |
Yi-yang Hu. Pay attention to the study on active antiliver fibrosis components of Chinese herbal medicine. Chinese Journal of Integrative Medicine 2012; 18(8) doi: 10.1007/s11655-012-1029-7
|
| 101 |
Di Zhao, Zi‐dong Gao, De‐en Han, Ning Li, Yong‐jie Zhang, Yang Lu, Ting‐ting Li, Xi‐jing Chen. Influence of Rifampicin on the Pharmacokinetics of Salvianolic Acid B May Involve Inhibition of Organic Anion Transporting Polypeptide (Oatp) Mediated Influx. Phytotherapy Research 2012; 26(1) doi: 10.1002/ptr.3522
|
| 102 |
Yang Tan, Yuyan Li, Feng Zhou, Jinming Guo, Tao Wang, Yuhe Shi, Yantao Yang, Jiandong Lu, Gang Pei. Administration of a mixture of triterpenoids from yeyachun and phenolic acids from danshen ameliorates carbon tetrachloride-induced liver fibrosis in mice by the regulation of intestinal flora. Journal of Pharmacological Sciences 2020; 143(3) doi: 10.1016/j.jphs.2020.04.007
|
| 103 |
Alessandro Siani. Pharmacological Treatment of Fibrosis: a Systematic Review of Clinical Trials. SN Comprehensive Clinical Medicine 2020; 2(5) doi: 10.1007/s42399-020-00292-2
|